4BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A

4BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science

Ray Therapeutics Receives $4M in Funding from the California Institute for Regenerative Medicine

4BIO Capital announces promotion of Owen Smith to Partner and Vasily Fedorin to COO

Code Biotherapeutics Announces Collaboration with Takeda

4BIO Capital Portfolio Company Carisma to Collaborate with Moderna